
Remdesivir
Form: Tablets
Strength: 100 mg
Reference Brands:
Category: Anti Covid Medicines
Remdesivir is not approved by the FDA to treat pediatric patients weighing 8 pounds (3.5 kilograms) to less than 88 pounds (40 kilograms) or younger than 12 years of age who weigh at least 8 pounds (3.5 kilograms).
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Baricitinib
Strength: 2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View DetailsNirmatrelvir + Ritonavir
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View DetailsTocilizumab
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details